[ad_1] Novartis management has achieved the positive results they have been expecting from Entresto's PIONEER-HF study to confirm accelerated sales of heart medicines. Initially slow, prevented by reluctant doctors from adopting a …
Read More »Novartis and Pfizer team up for liver disease medications
[ad_1] Novartis AG (NOVN.EB) and Pfizer Inc. PFE, -1.87% They are teaming up to target a complex type of liver disease, highlighting the drug companies' growing desire to work with their rivals …
Read More »Esmo 2018 – Novartis hopes to succeed where Roche failed
[ad_1] A year ago, data from the Lorelei trial on the taselisib aspirator, Roche's PI3K inhibitor, finally failed and the project was abandoned. Today, at Esmo, Novartis has unveiled the full results …
Read More »Endocyte anticancer drug provider increases 50% after Novartis agrees to buy it for $ 2.1 billion (ECYT, NVS)
[ad_1] Reuters The Swiss drug manufacturer Novartis has agreed to buy the US endocyte cancer treatment provider for $ 2.1 billion. Under this agreement, Novartis will pay $ 24 per share in …
Read More »Endocyte shares up 50% as part of a $ 2.1 billion deal with Novartis
[ad_1] Endocyte shares rose about 50% in pre-market trading after Swiss drug maker Novartis agreed to buy US-based biopharmaceutical company for $ 2.1 billion of dollars.
Read More »Novartis embarks on nuclear medicine with $ 2.1 billion contract
[ad_1] ZURICH (Reuters) – Novartis (NOVN.S) pays $ 2.1 billion for nuclear medicine specialist Endocyte (ECYT.O) in the latest agreement of the CEO, Vas Narasimhan, aiming to turn the Swiss pharmaceutical group …
Read More »Novartis embarks on nuclear medicine with $ 2.1 billion contract
[ad_1] ZURICH (Reuters) – Novartis (NOVN.S) pays $ 2.1 billion (£ 1.6 billion) for nuclear medicine specialist Endocyte (ECYT.O) in the latest agreement of the CEO, Vas Narasimhan, aiming to turn the …
Read More »Novartis to cut 2,550 jobs in Switzerland
[ad_1] ZURICH (Reuters) – Novartis (NOVN.Swill cut 2,550 jobs in Switzerland and Britain in four years, said Tuesday the Swiss pharmaceutical group, which strives to boost profits and focus on new drugs. …
Read More »Novartis Sells Parts of Sandoz US in Aurobindo, India for $ 900 Million
[ad_1] (Reuters) – Novartis AG (NOVN.Sannounced Thursday that it would sell Sandoz U.S.'s American dermatological and generic product portfolios in the US to Aurobindo Pharma Ltd (ARBN.NS) for $ 900 million, the …
Read More »Novartis migraine medication gets approval from EMA
[ad_1] The EMA has approved Aimovig of Norvartis (erenumab), making it the first European treatment specifically designed to prevent migraine . The drug works by blocking the calcitonin gene. related peptide receptor …
Read More »